학술논문
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects
Document Type
Article
Author
Source
In International Journal of Pharmaceutics 15 June 2016 506(1-2):268-279
Subject
Language
ISSN
0378-5173